[{"address1": "201 East Fifth Street", "address2": "Suite 1900", "city": "Cincinnati", "state": "OH", "zip": "45202", "country": "United States", "phone": "513 620 4101", "website": "https://onconetix.gcs-web.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ralph  Schiess Ph.D.", "age": 44, "title": "Interim CEO & Chief Science Officer", "yearBorn": 1979, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karina M. Fedasz", "age": 50, "title": "Interim Chief Financial Officer", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian  Price Ph.D.", "title": "Head of Technology Strategy", "fiscalYear": 2020, "totalPay": 126479, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew D. Skibo Ph.D.", "title": "Global Head of Biologics Operations", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Theodore Scott Yoho", "title": "Head of Business Development", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ali I. Fattom Ph.D.", "title": "Head of Science & Discovery", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jay  Newmark M.B.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian  Bruhlmann", "age": 46, "title": "Chief Strategy Officer & GM of Europe", "yearBorn": 1977, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Donald L. Very Jr., Ph.D.", "title": "Senior VP of Commercial Research & Development", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1609372800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.63, "open": 0.618, "dayLow": 0.61, "dayHigh": 0.6459, "regularMarketPreviousClose": 0.63, "regularMarketOpen": 0.618, "regularMarketDayLow": 0.61, "regularMarketDayHigh": 0.6459, "beta": 3.727, "forwardPE": -0.7432941, "volume": 57102, "regularMarketVolume": 57102, "averageVolume": 730457, "averageVolume10days": 377280, "averageDailyVolume10Day": 377280, "bid": 0.5886, "ask": 0.6571, "bidSize": 100, "askSize": 100, "marketCap": 5240610, "fiftyTwoWeekLow": 0.591, "fiftyTwoWeekHigh": 21.4, "priceToSalesTrailing12Months": 3.580273, "fiftyDayAverage": 3.1253, "twoHundredDayAverage": 5.27829, "currency": "USD", "enterpriseValue": 21900474, "floatShares": 313727, "sharesOutstanding": 8294730, "sharesShort": 33333, "sharesShortPriorMonth": 20287, "sharesShortPreviousMonthDate": 1728950400, "dateShortInterest": 1731628800, "sharesPercentSharesOut": 0.004, "heldPercentInsiders": 0.57928, "heldPercentInstitutions": 0.07863, "shortRatio": 0.45, "shortPercentOfFloat": 0.0072000003, "impliedSharesOutstanding": 8294730, "bookValue": -64.144, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -53123056, "trailingEps": -109.2, "forwardEps": -0.85, "lastSplitFactor": "1:40", "lastSplitDate": 1727136000, "enterpriseToRevenue": 14.962, "enterpriseToEbitda": -1.446, "52WeekChange": -0.93389124, "SandP52WeekChange": 0.31754446, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ONCO", "underlyingSymbol": "ONCO", "shortName": "Onconetix, Inc.", "longName": "Onconetix, Inc.", "firstTradeDateEpochUtc": 1645194600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "32a5d7e9-d675-3883-aeca-199596981307", "messageBoardId": "finmb_600261365", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.6318, "recommendationKey": "none", "totalCash": 930541, "totalCashPerShare": 1.249, "ebitda": -15146995, "totalDebt": 15278488, "quickRatio": 0.056, "currentRatio": 0.099, "totalRevenue": 1463746, "revenuePerShare": 2.892, "returnOnAssets": -0.21851999, "freeCashflow": -6060771, "operatingCashflow": -15783840, "grossMargins": -0.57213, "operatingMargins": -3.00331, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]